Desh Rakshak Aushdhalaya Quarterly Results for Trading Insights
DESHRAK • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹1 Cr
QMarch 2025
Desh Rakshak Aushdhalaya Quarterly Results Key Highlights
- Revenue of ₹6 Cr in March 2025 (+0.0% vs March 2025, +0.0% vs March 2024)
- Net Profit of ₹1 Cr in March 2025 (+0.0% vs March 2025)
- EBITDA of ₹1 Cr in March 2025 (+0.0% vs March 2025)
- Operating Margin of 20.0% in March 2025 (+0.0pp vs March 2025)
- Earnings Per Share of ₹1.07 in March 2025 (+0.0% vs March 2025)
Desh Rakshak Aushdhalaya Quarterly Results Analysis
| Metric | 2026 | March 2025 | March 2024 | March 2023 | March 2022 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 9 | 6 | 6 | 6 | 6 | 50.0% | - |
| Net Profit (₹ Cr) | 1 | 1 | 0 | 0 | 1 | - | - |
| EBITDA (₹ Cr) | 2 | 1 | 1 | 1 | 1 | - | - |
| EPS (₹) | 1.40 | 1.07 | 0.96 | 0.91 | 1.08 | - | - |
| Operating Margin (%) | 21.0% | 20.0% | 21.0% | 21.0% | 19.0% | - | - |
Desh Rakshak Aushdhalaya Share Price Trend Around Quarterly Results
Visualize Desh Rakshak Aushdhalaya's 1-year price movement across quarterly results — ideal for logging trades in Desh Rakshak Aushdhalaya share price
chart using Tickjournal. All values in ₹.
Related Pages for Desh Rakshak Aushdhalaya
Additional stock information and data for DESHRAK
Revenue Trend (₹ Cr)
March 2023
6
March 2024
6
March 2025
6
2026
9
Net Profit Trend (₹ Cr)
March 2023
0
March 2024
0
March 2025
1
2026
1
Operating Margin Trend (%)
March 2023
21.0%
March 2024
21.0%
March 2025
20.0%
2026
21.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Desh Rakshak Aushdhalaya quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹416,764.48 Cr | 1807.4 | 14,875 | 3,125 | +10.8% | - | 21.0% | 139.0 |
|
Divis Laboratories
Sept 2025 |
₹170,125.54 Cr | 6330.0 | 2,860 | 689 | +7.1% | - | 24.1% | 243.7 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹146,658.56 Cr | 4373.7 | 3,219 | 591 | +11.3% | - | 18.4% | 249.4 |
|
Cipla
Sept 2025 |
₹109,178.44 Cr | 1325.0 | 7,716 | 1,353 | +12.0% | - | 17.5% | 79.2 |
|
Dr Reddys Laborator…
Sept 2025 |
₹107,358.50 Cr | 1287.0 | 9,135 | 1,337 | +1.1% | - | 14.6% | 79.5 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores